Position in SLS
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$66,420,000
+$56,706,970 QoQ
Shares Held
4,500,000
-25.4% QoQ
Ownership
2.23%
of shares outstanding
% of Portfolio
7.67%
of 13F equity value
Holder Rank
#5
of 189 holders
Holding Since
Mar 2024
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in SLS Over Time
Shares Held
Position Value (USD)
Derivatives in SLS
reported options exposure · as of Jun 30, 2026CallValue
$11,808,000
CallShares
800,000
PutValue
$27,245,484
PutShares
1,845,900
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026Anson Funds Management LP holds $75,470,163 across 8 Biotechnology names. SLS ranks #1 (88.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | SLS |
SELLAS Life Sciences Group, Inc.
This page
|
4,500,000 | $66,420,000 | |
| 2 | RVMD |
Revolution Medicines, Inc.
|
20,000 | $3,745,600 | |
| 3 | NKTR |
Nektar Therapeutics
|
40,535 | $2,829,748 | |
| 4 | RNA |
Atrium Therapeutics, Inc.
|
125,000 | $1,681,250 | |
| 5 | CAPR |
Capricor Therapeutics, Inc.
|
25,000 | $602,000 | |
| 6 | CELZ |
Creative Medical Technology Holdings, Inc.
|
105,549 | $153,046 | |
| 7 | OABI |
OmniAb, Inc.
|
11,833 | $29,109 | |
| 8 | YARW |
Yarrow Bioscience, Inc.
|
289 | $9,410 |
All Filings in SLS
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $66,420,000 | 4,500,000 | Shares | Defined | 2026-08-13 | |
| 2026-06-30 | $27,245,484 | 1,845,900 | Put | Defined | 2026-08-13 | |
| 2026-06-30 | $11,808,000 | 800,000 | Call | Defined | 2026-08-13 | |
| 2025-09-30 | $9,713,030 | 6,032,938 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $602,250 | 275,000 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $8,185,422 | 7,579,095 | Shares | Defined | 2025-05-28 | |
| 2024-12-31 | $1,239,956 | 1,192,266 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $992,293 | 793,835 | Shares | Defined | 2024-11-15 | |
| 2024-03-31 | $4,880,691 | 4,832,368 | Shares | Defined | 2024-05-14 | |
| No filing history on record for this holder in this stock. | ||||||